Results 21 to 30 of about 285,878 (344)
Clinical Case Reports, 2021 COVID‐19 infection may have extrapulmunary manifestations such as blood hypercoagulability that may cause thrombosis in both arterial and venous system. Deep dorsal penile vein thrombosis is very rare, and the most common reason is coagulation disorders.
Seyed Morteza Bagheri, Zhale Tabrizi
doaj +1 more source
Cost‐effectiveness of second‐line therapies in adults with chronic immune thrombocytopenia
American Journal of Hematology, Volume 98, Issue 1, Page 122-130, January 2023., 2023 Abstract Major options for second‐line therapy in adults with chronic immune thrombocytopenia (ITP) include splenectomy, rituximab, and thrombopoietin receptor agonists (TRAs). The American Society of Hematology guidelines recommend rituximab over splenectomy, TRAs over rituximab, and splenectomy or TRAs while noting a lack of evidence on the cost ...
George Goshua +5 more
wiley +1 more source
Interrupting vaccination policies can greatly spread SARS-CoV-2 and enhance mortality from COVID-19 disease: the AstraZeneca case for France and Italy [PDF]
, 2021 Several European countries have suspended the inoculation of the AstraZeneca vaccine out of suspicion of causing deep vein thrombosis. In this letter we report some Fermi estimates performed using a stochastic model aimed at making a risk-benefit analysis of the interruption of the delivery of the AstraZeneca vaccine in France and Italy.
arxiv +1 more source
Romiplostim use in pregnant women with immune thrombocytopenia
American Journal of Hematology, Volume 98, Issue 1, Page 31-40, January 2023., 2023 Abstract Treatment for immune thrombocytopenia (ITP) in pregnancy is hampered by the lack of fetal safety evidence of maternally‐administered medications. The Pregnancy Surveillance Program (PSP) collected patient information from 2017–2020 for pregnancy, birth outcomes, and adverse events (AEs) for 186 women exposed to romiplostim from 20 days before ...
James B. Bussel +7 more
wiley +1 more source
Journal of Medical Case Reports, 2022 Background Deep vein thrombosis with arteriovenous fistulas is rare, with few therapeutic options available for chronic-phase deep vein thrombosis.
Tamon Kato +13 more
doaj +1 more source
Mortality of Patients Infected by COVID-19 with and without Deep-Vein Thrombosis
Medicines, 2021 Background: Current evidence points to a state of hypercoagulability (consequence of hyperinflammation) as an important pathogenic mechanism that contributes to the increase in mortality in cases of COVID-19.
Jose Maria Pereira de Godoy +7 more
doaj +1 more source
Towards the Generation of Synthetic Images of Palm Vein Patterns: A Review [PDF]
Information Fusion 89 (2023) 66-90, 2022 With the recent success of computer vision and deep learning, remarkable progress has been achieved on automatic personal recognition using vein biometrics. However, collecting large-scale real-world training data for palm vein recognition has turned out to be challenging, mainly due to the noise and irregular variations included at the time of ...
arxiv +1 more source
The frequencies of fv leiden and fii g20210a mutations in patients with different clinical manifestations of venous thromboembolism: experience from large Serbian cohort [PDF]
, 2016 Venous thromboembolism is a multifactorial disorder with two manifestations: deep-vein thrombosis and pulmonary embolism. Pulmonary embolism is usually considered as the complication of deep-vein thrombosis, but there are reported cases of isolated ...
Antonijević, Nebojša +6 more
core +1 more source
AAOHN Journal, 2008 This article reviews the incidence, causes, risk factors, diagnosis, treatment, complications, and prevention of deep vein thrombosis (DVT). Various employees, including long-distance drivers or travelers, sedentary office workers, females taking estrogen, those who are obese, those who have cancer, and those who are hospitalized, may be at risk for ...
openaire +3 more sources
Molecular Analysis of Prothrombotic Gene Variants in Venous Thrombosis: A Potential Role for Sex and Thrombotic Localization [PDF]
, 2020 Background: Requests to test for thrombophilia in the clinical context are often not evidence-based. Aim: To define the role of a series of prothrombotic gene variants in a large population of patients with different venous thromboembolic diseases ...
AMATO, FELICE +9 more
core +1 more source